Displaying 1–8 of 8 results for Large Molecule
In this special report, we explore how virtualization can provide significant advantages for deploying process control systems at pharmaceutical plants.
The high risk involved with biopharmaceuticals means there are high demands placed on the hygienic design of bioprocessing equipment. Instrument connections on equipment are a known challenge in preventing process contamination, especially when they aren’t properly installed or maintained.
Parenteral drugs are taking a strong position alongside the more established oral solid dose forms and are quickly coming into their own
Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed, it is clear that Biopharma is soaring.
When it comes to the biologics product development lifecycle, information management is an imperative that cannot be ignored.
The Best of Pharmaceutical Manufacturing eBook is a collection of the most-read feature articles from 2014, chosen by the Pharmaceutical Manufacturing digital audience.
Many pharmaceutical companies, large and small, have made considerable investments in the past several years in the development of various biotherapeutics (monoclonal antibodies, vaccines, proteins, peptides, nucleic acids, etc.). In the past few years, the number of biological pharmaceuticals ...
As scientists in Pharmaceutical and Analytical Development groups are called upon to identify an ever varying and always increasing number of APIs and unknown or unexpected impurities, many researchers are looking for more high performance analytical tools to better deal with these complex ...